- Full Year 2023 Croda International PLC Earnings Presentation TranscriptFeb 27, 2024
- Q3 2023 Croda International PLC Trading Statement Call TranscriptOct 09, 2023
- Half Year 2023 Croda International PLC Earnings Presentation TranscriptJul 25, 2023
- Q1 2023 Croda International PLC Trading Statement Call TranscriptJun 09, 2023
- Croda International PLC at Deutsche Bank dbAccess Global Consumer Conference TranscriptJun 06, 2023
- Full Year 2022 Croda International PLC Earnings Call TranscriptFeb 28, 2023£65.78 (-4.58%)Earnings
- Croda International PLC Investor Seminar: Healthcare business TranscriptOct 07, 2022
- Half Year 2022 Croda International PLC Earnings Call TranscriptJul 29, 2022£75 (+5.54%)Earnings
- Croda International PLC Site Visit and Investor Presentation TranscriptMay 12, 2022
- Croda International PLC Consumer Care Seminar TranscriptMar 29, 2022
- Full Year 2021 Croda International PLC Earnings Presentation TranscriptMar 01, 2022
- Half Year 2021 Croda International PLC Earnings Presentation TranscriptJul 27, 2021
- Croda International PLC Sustainability Report Call TranscriptMar 25, 2021
- Full Year 2020 Croda International PLC Earnings Call TranscriptMar 02, 2021£63.26 (+0.38%)Earnings
- Croda International PLC to Discuss Acquisition with Iberchem and Propose Placing of Shares Call TranscriptNov 18, 2020
- Croda International PLC Investor Teach-In on Sustainability (Virtual) TranscriptOct 20, 2020
- Half Year 2020 Croda International PLC Earnings Presentation TranscriptJul 23, 2020
- Full Year 2019 Croda International PLC Earnings Presentation TranscriptFeb 25, 2020
- Half Year 2019 Croda International PLC Earnings Presentation TranscriptJul 24, 2019
- Full Year 2018 Croda International PLC Earnings Presentation TranscriptFeb 26, 2019
Croda International PLC to Discuss Acquisition with Iberchem and Propose Placing of Shares Call Transcript
Welcome to the Croda call. Shortly, I will hand over to your host, Steve Foots, Croda's Chief Executive. At the end of the presentation, there will be a Q&A session.
Steve, over to you.
Thank you, and morning, everybody. Yes. Here I am with Jez and Dave Bishop and we'll spend about 20 minutes going through the presentation and the rationale about Iberchem and why F&F and what we really want to do in this space and also plenty of time to ask questions along the way. So I'm going to try and rattle through the slide pack with Jez and then please build your questions up and then we'll -- as I said, we'll take that.
So putting this context on Slide 6. This is the grand plan. Part of the grand plan is to move Croda to more of a pure-play consumer ingredients business, and central to that is expanding our Life Science business. And you've seen with our Avanti acquisition and the connections with Pfizer that we're well on track there. We don't need
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)